M Bertello, E Cinotti, P Rubegni, L Mastorino, G Passaro, M Ortoncelli, P Quaglino, S Ribero
{"title":"乌达帕替尼治疗中重度特应性皮炎:中重度特应性皮炎患者的乌达帕替尼:长期疗效、安全性以及临床疗效与疾病主观感受之间相关性的实际生活研究。","authors":"M Bertello, E Cinotti, P Rubegni, L Mastorino, G Passaro, M Ortoncelli, P Quaglino, S Ribero","doi":"10.1089/derm.2024.0346","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":"545-548"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of Disease.\",\"authors\":\"M Bertello, E Cinotti, P Rubegni, L Mastorino, G Passaro, M Ortoncelli, P Quaglino, S Ribero\",\"doi\":\"10.1089/derm.2024.0346\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93974,\"journal\":{\"name\":\"Dermatitis : contact, atopic, occupational, drug\",\"volume\":\" \",\"pages\":\"545-548\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatitis : contact, atopic, occupational, drug\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/derm.2024.0346\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatitis : contact, atopic, occupational, drug","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/derm.2024.0346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of Disease.